随着越来越多的家庭重视儿童生长发育，儿童膳食补充剂市场蓬勃发展，不断吸引创新者涌入，agebox 旗下产品阿基孚就是其中的典型代表。 阿基孚聚焦生长发育核心的"GH-IGF-1轴"，以独特的"IGF-1增敏剂"定位另辟蹊径，自2022年底进入中 国市场以来，就迅速赢得广泛关注。数据显示，其儿童用户数已超过5万人，用户综合复购率达70%。 一款创新产品在短时间内取得如此成绩，实属不易。亮眼市场表现的背后，究竟有何独到之处？阿基孚 何以快速崛起为行业佼佼者？让我们一探究竟。 动植物提取物为原料，核心成分如何实现应用价值？ 据公开信息，阿基孚的主要成分为纯天然动植物提取物，包含牡蛎精华提取物、黄芪提取物、南非钩麻 提取物、东革阿里提取物等。有研究表明，这些成分在促进生长发育及增强免疫力方面具有潜在功效。 据了解，在研发之初，阿基孚就确定使用纯天然动植物原料，目的就是为了在源头保证产品安全性，给 儿童提供健康有效的产品。 许多纯天然动植物已经有悠久的食用、药用历史，比如黄精、冬虫夏草、石斛、麝香等。如今依托现代 科技，这些动植物的活性成分被高效提取与利用，应用价值显著提升。 以市场上热销的产品为例，破壁灵芝孢子粉具有 ...

Core Insights - The article discusses the emerging opportunities in the children's height enhancement market, which has been largely dominated by growth hormones, highlighting the potential for new entrants like Akif to capture a share of the market [1][2]. Market Overview - The current height enhancement market primarily focuses on children below the P3 height percentile, which corresponds to the shortest 3 out of 100 children [2]. - There is a growing demand from non-short stature children (above P3) who wish to increase their height for better life opportunities, indicating a shift in consumer needs [2]. Product Insights - Akif's core product, "IGF-1 Growth Factor Sensitizer," aims to enhance children's sensitivity to growth factors through dietary supplementation, providing a scientific and safe approach to height enhancement [2][4]. - The product operates on the GH-IGF-1 axis, promoting growth by increasing the expression of IGF-1 and enhancing the sensitivity of growth plate cartilage cells [4]. Clinical Research and Development - Akif has initiated six clinical studies in China to validate the efficacy of the "IGF-1 Growth Factor Sensitizer," targeting various growth-related conditions in children [4][5]. - The company emphasizes the importance of clinical data to differentiate its product from ineffective alternatives in the market [4]. Marketing Strategy - Akif's marketing strategy has focused on organic growth through word-of-mouth and user education rather than traditional advertising, leveraging the unmet demand in the market [5][6]. - The company aims to establish a clear height management philosophy among parents, promoting the idea of using Akif's product for children above the P3 height threshold [6]. Expansion Plans - China is identified as a key market for Akif, with plans to expand into Japan, South Korea, and Southeast Asia by 2025, capitalizing on the strong demand for height enhancement in these regions [6]. - The acceptance of dietary supplements in these markets is notably higher, with consumers more willing to explore innovative solutions for height enhancement [6]. Research and Development Platform - Akif has established a drug screening platform based on primary cells, which allows for the development of various dietary supplement formulations, including over 50 different recipes [6]. - The platform supports research into complex health issues, enabling the company to innovate beyond height enhancement products to address other health concerns in children [6].